EUS-guided core biopsies of pancreatic solid masses using a new fork-tip needle: A multicenter prospective study

被引:39
|
作者
Di Leo, Milena [1 ,2 ]
Crino, Stefano Francesco [3 ]
Bernardoni, Laura [3 ]
Rahal, Daoud [4 ]
Auriemma, Francesco [1 ]
Correale, Loredana [6 ]
Donato, Giulio [5 ]
Massidda, Marco [1 ]
Anderloni, Andrea [1 ]
Manfrin, Erminia [7 ]
Armellini, Elia [5 ]
Poliani, Laura [1 ]
Fugazza, Alessandro [1 ]
Semeraro, Rossella [1 ]
Occhipinti, Pietro [5 ]
Repici, Alessandro [1 ,2 ]
Carrara, Silvia [1 ]
机构
[1] Humanitas Res Hosp, Div Gastroenterol, Digest Endoscopy Unit, Via Manzoni 56, I-20089 Milan, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] GB Rossi Univ Hosp, Pancreas Inst, Gastroenterol & Digest Endoscopy Unit, Verona, Italy
[4] Humanitas Res Hosp, Pathol Dept, Milan, Italy
[5] Osped Maggiore La Carita, Digest Endoscopy Unit, Novara, Italy
[6] Ctr Prevenz Oncol, Turin, Italy
[7] GB Rossi Univ Hosp, Dept Diagnost & Publ Hlth, Verona, Italy
关键词
FNA; FNB; Pancreatic adenocarcinoma; SharkCore needle; Tissue acquisition; DIAGNOSTIC-ACCURACY; TISSUE ACQUISITION; ASPIRATION; LESIONS; 22-GAUGE; FNA; TRIAL;
D O I
10.1016/j.dld.2019.03.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: Endoscopic ultrasound-guided sampling (EUS sampling) is a safe and effective technique. The study aim was to evaluate the presence of a histological core from pancreatic lesions using a new 25G fork-tip needle. Methods: Observational multicenter prospective and analytical study, including consecutive patients with solid pancreatic masses referred for EUS-guided sampling. At each needle pass, the endoscopist performed macroscopic on-site evaluation (MOSE). The primary outcome was the histological core procurement rates. Secondary outcomes were the evaluation of interobserver agreement between endoscopists and pathologists, adequacy of EUS samples for the diagnosis and post-procedure adverse events. Results: 100 patients were enrolled in 3 centers. The mean size of the lesions was 28.5 mm (SD 11.7). Final diagnoses were adenocarcinoma (68%), neuroendocrine tumor (21%), inflammatory mass/benign lesions (8.0%), and pancreatic metastasis (3.0%). The pathologists described the presence of a core in 67 samples (67.0% of patients), with poor agreement with MOSE (kappa, 0. 12; 95% CI: 0.03-0.28). The diagnostic accuracy was 93%. We observed 6% of mild adverse events. Conclusion: The new 25-gauge core needle showed good overall adequacy and a good rate of histological specimens during EUS sampling of solid pancreatic masses, with a minimum number of passes and no major complications. (C) 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1275 / 1280
页数:6
相关论文
共 50 条
  • [41] A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore™) with the 22-gauge needle in patients with solid pancreatic mass lesions
    Naveed, Mariam
    Siddiqui, Ali A.
    Kowalski, Thomas E.
    Loren, David E.
    Khalid, Ammara
    Soomro, Ayesha
    Mazhar, Syed M.
    Yoo, Joseph
    Hasan, Raza
    Yalamanchili, Silpa
    Tarangelo, Nicholas
    Taylor, Linda J.
    Adler, Douglas G.
    ENDOSCOPIC ULTRASOUND, 2018, 7 (01) : 34 - 40
  • [42] Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study
    Kanno, Atsushi
    Masamune, Atsushi
    Fujishima, Fumiyoshi
    Iwashita, Takuji
    Kodama, Yuzo
    Katanuma, Akio
    Ohara, Hirotaka
    Kitano, Masayuki
    Inoue, Hiroyuki
    Itoi, Takao
    Mizuno, Nobumasa
    Miyakawa, Hiroyuki
    Mikata, Rintaro
    Irisawa, Atsushi
    Sato, Satoko
    Notohara, Kenji
    Shimosegawa, Tooru
    GASTROINTESTINAL ENDOSCOPY, 2016, 84 (05) : 797 - +
  • [43] Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses
    Harewood, GC
    Wiersema, LM
    Halling, AC
    Keeney, GL
    Salamao, DR
    Wiersema, MJ
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (06) : 669 - 673
  • [44] High-Throughput Sequencing of EUS-Guided Pancreatic Fine Needle Aspiration Biopsies
    Rodriguez, Sarah
    Morgan, Terry
    Impey, Soren
    DuPriest, Elizabeth
    Faigel, Douglas O.
    GASTROENTEROLOGY, 2009, 136 (05) : A274 - A275
  • [45] Evaluation of the SharkCore® needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors
    Witt, Benjamin L.
    Factor, Rachel E.
    Chadwick, Barbara E.
    Caron, Justin
    Siddiqui, Ali A.
    Adler, Douglas G.
    ENDOSCOPIC ULTRASOUND, 2018, 7 (05) : 323 - 328
  • [46] EUS-guided fine needle biopsy of pancreatic masses can yield true histology
    Bang, Ji Young
    Hebert-Magee, Shantel
    Navaneethan, Udayakumar
    Hasan, Muhammad K.
    Hawes, Robert
    Varadarajulu, Shyam
    GUT, 2018, 67 (12) : 2081 - +
  • [47] Prospective evaluation of EUS-guided fine needle biopsy in pancreatic mass lesions
    Larsen, M. H.
    Fristrup, C. W.
    Detlefsen, S.
    Mortensen, M. B.
    ENDOSCOPY INTERNATIONAL OPEN, 2018, 6 (02) : E242 - E248
  • [48] EUS-Guided fine needle aspiration (EUS-FNA) with and without EUS-Guided trucut biopsy (EUS-TCB) of pancreatic masses: A single center experience
    Mubashir, S.
    Shah, A.
    Rocha-Lima, Caio
    Ganjei-Azar, Parvin
    Jorda, Merce
    Levi, Joe
    Ribeiro, Afonso C.
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB308 - AB308
  • [49] EUS-GUIDED PANCREATIC CYST WALL BIOPSY USING A NOVEL THROUGH-THE-NEEDLE FORCEPS: A RETROSPECTIVE MULTICENTER STUDY
    Barresi, L.
    Crino, S. F.
    Fabbri, C.
    Carrara, S.
    Tarantino, I.
    Bernardoni, L.
    Attili, F.
    Di Leo, M.
    Fornelli, A.
    Larghi, A.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E89 - E89
  • [50] TRANSESOPHAGEAL EUS-GUIDED CORE BIOPSY OF LUNG MASSES USING 22G FRANSEEN-TIP NEEDLE-INITIAL EXPERIENCE
    Karagyozov, Petko
    Boeva, Irina
    Tishkov, Ivan
    Minchev, Tsvetan R.
    Dakova, Polina
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB304 - AB304